The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
April 22nd 2024
Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 2024
Register Now!
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Optimal Approaches to Recognizing and Treating ANCA-Associated Vasculitis
View More
Evaluating an Online Wellness Program for Patients with Psoriatic Arthritis
“There's a real interest and need for wellness programs out there among people living with psoriatic arthritis. This is something that matters to them even more now living with a chronic disease.”
Rheumatoid Arthritis Quiz: Integrative Management of RA
November 16th 2022Taking an integrative approach to management by using a combination of therapies and lifestyle changes to treat the whole person can have benefits for many conditions, such as cardiovascular disease and diabetes. How does this approach fit in with the management of rheumatoid arthritis? Test your knowledge with this quiz.
Examining Drivers of Cardiovascular Risk with Tofacitinib, with Deepak Bhatt, MD, MPH
November 15th 2022Deepak Bhatt, MD, MPH, discusses a posthoc analysis of the ORAL Surveillance trial examining drivers of increased cardiovascular risk observed in the phase 3b/4 trial in patients with rheumatoid arthritis.
Trial Finds 1-Week Methotrexate Hold As Effective for Vaccine Response as 2-Week Hold
November 14th 2022A trial comparing a 1-week methotrexate hold following seasonal influenza vaccination against the standard 2-week hold among patients with rheumatoid arthritis using methotrexate suggests there were no significant differences in positive vaccine response with either approach.
Q&A: A Quick Quantitative C-Reactive Protein Assay-Based DAPSA in Patients With Psoriatic Arthritis
November 14th 2022In this Q&A, Fabian Proft, MD, discussed the findings of his study that evaluated the DAPSA using a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis.
Deucravacitinib Shows Promise for Systemic Lupus Erythematosus in Phase 2 Trial
November 13th 2022Data from a phase 2 trial presented at ACR Convergence 2022 provides clinicians with insight into the effects of deucravacitinib, a TYK2 inhibitor, in patient populations with systemic lupus erythematosus.
Belimumab Provides Benefit in Cutaneous Lupus Erythematosus, With or Without SLE
November 13th 2022A systematic review and meta-analysis presented at ACR Convergence 22 provide insight into the effects of belimumab in patient populations with cutaneous lupus erythematosus, with or without systemic lupus erythematosus.
Daniel Hernandez, MD: Determining the Educational Needs of Hispanic Patients with RA
“It’s very possible to reach the Hispanic community and to go above and beyond what is currently being done, which is very little in terms of supporting them and giving them the tools that they need to create to have a better quality of life."
Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increase Cardiovascular Risk
November 12th 2022An analysis of more than 17,000 Veterans suggests early initiation of TNF inhibitor therapy in patients with ankylosing spondylitis was associated with an increased risk of incident cardiovascular disease and major adverse cardiovascular events.